The Soluble Guanylyl Cyclase (sGC) Activator BAY 58-2667 Selectively Limits Cardiomyocyte Hypertrophy - A Potential Therapeutic Advantage for Managing Left Ventricular Hypertrophy (LVH) Conference Paper uri icon

authors

  • Ritchie, Rebecca H
  • Irvine, Jennifer C
  • Ganthavee, Virat
  • Love, Jane E
  • Alexander, Amy E
  • Horowitz, John D
  • Stasch, Johannes-Peter
  • Kemp-Harper, Barbara K

publication date

  • November 20, 2012